CROSSLEAD Standard 035 and CROSSLEAD Stiff 035
Filmecc Co., Ltd. · Decision date Sep 3, 2026
What did the FDA decide?
Filmecc Co., Ltd. received a substantially equivalent (SESE) decision from FDA on 2026-09-03 for CROSSLEAD Standard 035 and CROSSLEAD Stiff 035, filed as 510(k) K261281 and received 04/17/2026. The listed classification is Wire, Guide, Catheter under regulation 870.1330, product code DQX, with a Cardiovascular specialty and review panel. A SESE decision is a 510(k) clearance, not a PMA approval.
The record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public page does not state what distinguishes the Standard 035 from the Stiff 035 configuration, what predicate device was cited, or what nonclinical or clinical evidence supported the decision; those details would sit in the underlying 510(k) documents rather than this summary page.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261281
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Filmecc Co., Ltd.
- Product code
- DQX
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wire, Guide, Catheter.
- Applicant
- Filmecc Co., Ltd.
- Product code
- DQX
- FDA device class
- 2
FDA decision timeline
K261281 received
Application receipt date recorded by FDA.
K261281 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DQX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Skycade Med Corporation | 510(k) clearance | Oct 16, 2026 | FDA | |
Hyperdrive 35 GuidewireK253146 | Rapid-Medical , Ltd. | 510(k) clearance | Sep 18, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Filmecc Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Seto-Shi
Sources and methodology
- Original FDA record: K261281
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
